clonidine has been researched along with androstenedione in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (83.33) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Good, AC; Peterson, SJ; Richards, WG | 1 |
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Akaike, M; Hirai, M; Kumai, T; Masubuchi, Y; Tanaka, M; Watanabe, M | 1 |
| Henderson, CJ; Liu, Z; Rane, A; Wolf, CR | 1 |
| Bersi, C; Casarosa, E; Genazzani, AR; Luisi, M; Petraglia, F; Rubino, S; Stomati, M | 1 |
| Casarosa, E; Genazzani, AR; Luisi, S; Parrini, D; Petraglia, F; Rubino, S; Spinetti, A; Stomati, M | 1 |
2 trial(s) available for clonidine and androstenedione
| Article | Year |
|---|---|
Neuroendocrine effect of a short-term treatment with DHEA in postmenopausal women.
Topics: Administration, Oral; Androstenedione; beta-Endorphin; Clonidine; Dehydroepiandrosterone; Estrone; Female; Human Growth Hormone; Humans; Middle Aged; Neurosecretory Systems; Postmenopause; Sympatholytics; Testosterone | 1998 |
Endocrine, neuroendocrine and behavioral effects of oral dehydroepiandrosterone sulfate supplementation in postmenopausal women.
Topics: Administration, Oral; Adrenergic alpha-Antagonists; Androstenedione; Area Under Curve; beta-Endorphin; Climacteric; Clonidine; Dehydroepiandrosterone; Estradiol; Estrone; Female; Fluoxetine; Humans; Middle Aged; Multivariate Analysis; Naloxone; Narcotic Antagonists; Prospective Studies; Radioimmunoassay; Selective Serotonin Reuptake Inhibitors; Somatostatin; Testosterone | 1999 |
4 other study(ies) available for clonidine and androstenedione
| Article | Year |
|---|---|
QSAR's from similarity matrices. Technique validation and application in the comparison of different similarity evaluation methods.
Topics: Carbolines; Chemical Phenomena; Chemistry, Physical; Electrochemistry; Imidazoles; Indoles; Molecular Structure; Pyridines; Structure-Activity Relationship | 1993 |
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |
Disturbance or relatively important actions of antihypertensives, antifungal agent and opiate antagonist to the testicular steroidogenesis in rat.
Topics: Androstenedione; Animals; Antifungal Agents; Antihypertensive Agents; Clonidine; Estradiol; Ketoconazole; Male; Naloxone; Narcotic Antagonists; Prazosin; Rats; Testis; Testosterone; Verapamil | 1992 |
Divergent regulation of cytochrome P450 enzymes by morphine and pethidine: a neuroendocrine mechanism?
Topics: Adrenal Glands; Androstenedione; Animals; Aryl Hydrocarbon Hydroxylases; Base Sequence; Clonidine; Cortodoxone; Cytochrome P-450 Enzyme System; Cytochrome P450 Family 2; Desoxycorticosterone; Drug Interactions; Drug Therapy, Combination; Gene Expression Regulation; Isoenzymes; Kidney; Liver; Male; Meperidine; Molecular Sequence Data; Morphine; Neurosecretory Systems; Progesterone; Rats; Rats, Sprague-Dawley; RNA, Messenger; Steroid 16-alpha-Hydroxylase; Steroids; Yohimbine | 1995 |